SCHEMBL7843850

SCHEMBL7843850

C[SiH](C)Oc1ccnc(-c2cccc(N=C(N)NC(=O)OC(C)(C)C)c2)c1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 8/20 0.33
HRH4 Q9H3N8 8/20 0.33
SMO Q99835 4/20 0.33
ITGB3 P05106 1/20 0.32
ITGB1 P05556 1/20 0.32
ITGAV P06756 1/20 0.32
ITGA2B P08514 1/20 0.32
ITGB5 P18084 1/20 0.32
HRH3 Q9Y5N1 4/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
HRH1 P35367 3/20 0.31
ACACB O00763 1/20 0.31
ACACA Q13085 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843836 1.00 HRH2 (0.33) HRH2HRH4SMOITGB3ITGB1
SCHEMBL7236710 0.92 NPFFR1 (0.34) ITGB3ITGB1ITGAVITGA2BITGB5
SCHEMBL7846044 0.85 ITGB3 (0.34) HRH2HRH4ITGB3ITGB1ITGAV
SCHEMBL7846035 0.85 ITGB3 (0.34) HRH2HRH4ITGB3ITGB1ITGAV
SCHEMBL7237049 0.77 NPFFR1 (0.36) ITGB3ITGB1ITGAVITGA2BITGB5
SCHEMBL7843840 0.76 HRH2 (0.34) HRH2HRH4SMOITGB3ITGB1
SCHEMBL7228914 0.74 SIGMAR1 (0.41) HRH2HRH4SMOITGB3ITGB1
SCHEMBL7846039 0.73 HRH2 (0.36) HRH2HRH4ITGB3ITGB1ITGAV
SCHEMBL7240547 0.72 HRH2 (0.43) HRH2HRH4ITGB3ITGB1ITGAV
SCHEMBL7240551 0.72 HRH2 (0.43) HRH2HRH4ITGB3ITGB1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed